Use of biologic agents in idiopathic inflammatory myopathies in Sweden: a descriptive study of real life treatment. [electronic resource]
- Clinical and experimental rheumatology
- 512-515 p. digital
Publication Type: Journal Article
0392-856X
Adolescent Aged Anti-Inflammatory Agents--adverse effects Biological Products--adverse effects Drug Substitution Female Humans Interleukin 1 Receptor Antagonist Protein--therapeutic use Male Middle Aged Myositis--diagnosis Off-Label Use Registries Rituximab--therapeutic use Sweden--epidemiology Time Factors Treatment Outcome Tumor Necrosis Factor-alpha--antagonists & inhibitors Young Adult